Table 2.

Anti-proliferative activities of 5c, 5h, 6c, and 6h against MDA-MB-231, MCF-7, and HepG2 cancer cell lines.

Compound	IC50 (µM) 1
	MDA-MB-231		MCF-7		HepG2
	Normo	Hypo	Normo	Hypo	Normo	Hypo
5c	48.10 ± 3.23	46.23 ± 3.93	34.33 ± 2.85	28.12 ± 1.72	61.36 ± 5.75	69.43 ± 5.16
5h	75.25 ± 6.81	81.2 ± 7.34	63.84 ± 5.57	57.43 ± 5.50	81.41 ± 7.03	80.41 ± 7.14
6c	56.34 ± 4.19	61.56 ± 5.13	50.44 ± 4.73	47.04 ± 4.01	68.78 ± 4.17	62.78 ± 5.52
6h	54.23 ± 4.87	50.35 ± 4.27	41.36 ± 2.22	30.31 ± 3.14	58.23 ± 5.45	54.33 ± 5.15
Staurosporine	10.30 ± 0.51	10.55 ± 0.84	7.81 ± 0.59	7.65 ± 0.73	18.71 ± 1.45	17.78 ± 0.97

¹ IC₅₀ values represent an average of at least three independent experiments.